Warberg Asset Management’s Dermata Therapeutics, Inc. Warrant DRMAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30,000
| Closed | -$420 | – | 191 |
|
|
2024
Q2 | $420 | Hold |
30,000
| – | – | ﹤0.01% | 185 |
|
|
2024
Q1 | $285 | Hold |
30,000
| – | – | ﹤0.01% | 185 |
|
|
2023
Q4 | $210 | Hold |
30,000
| – | – | ﹤0.01% | 194 |
|
|
2023
Q3 | $525 | Hold |
30,000
| – | – | ﹤0.01% | 212 |
|
|
2023
Q2 | $575 | Sell |
30,000
-8,069
| -21% | -$155 | ﹤0.01% | 199 |
|
|
2023
Q1 | $1.32K | Sell |
38,069
-22,642
| -37% | -$785 | ﹤0.01% | 210 |
|
|
2022
Q4 | $1.21K | Sell |
60,711
-39,089
| -39% | -$782 | ﹤0.01% | 231 |
|
|
2022
Q3 | $9K | Sell |
99,800
-200
| -0.2% | -$18 | ﹤0.01% | 206 |
|
|
2022
Q2 | $11K | Hold |
100,000
| – | – | ﹤0.01% | 169 |
|
|
2022
Q1 | $16K | Buy |
100,000
+48,601
| +95% | +$7.78K | ﹤0.01% | 167 |
|
|
2021
Q4 | $22K | Sell |
51,399
-48,601
| -49% | -$20.8K | ﹤0.01% | 145 |
|
|
2021
Q3 | $85K | Buy |
+100,000
| New | +$85K | 0.01% | 119 |
|